How AI Transforms Early Breast Cancer Detection, and Improves Outcomes

Durvalumab Shows Significant Survival Benefit in Gastric and GEJ Cancer Treatment

How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer

FDA Approves Tislelizumab Plus Chemotherapy for PD-L1+ Metastatic Esophageal Cancer

A Breakthrough in Personalizing Lung Cancer Therapy with the GO Chip for Tumor Monitoring

CHMP Recommends Durvalumab Combination for EU Approval in Resectable NSCLC

Enhertu Gains EMA’s CHMP Support for HER2-Low Metastatic Breast Cancer Treatment

Camizestrant Plus CDK4/6 Inhibition Boosts PFS in ESR1+, HR+/HER2– Breast Cancer

Odronextamab Gains FDA Review for Hard-to-Treat R/R Follicular Lymphoma

KEYTRUDA Receives Priority FDA Review for Perioperative Use in ES Head and Neck Cancer

Patient Enrollment Completed in VAPOR 2 Trial for Vanquish Prostate Cancer Therapy

No More Doubts: CDK 4/6 inhibitor + ET as First-Line Standard for HR+ mBC

The Next Generation of ADCs and Their Potential for Non-Small Cell Lung Cancer

Nivolumab Plus Chemotherapy Demonstrates Significant Survival Benefit in Resectable NSCLC

AI in Life Sciences: Trends and Predictions for 2025 - By Doron Sitbon

How Bayer Shapes Strategic Partnerships for the Next Generation of Cancer Therapies

DNA-Based Immunotherapy IMNN-001 Promises to Improve Survival in Ovarian Cancer

New Data Confirms Darolutamide’s Safety and Efficacy in mHS Prostate Cancer

How AI Innovations Are Transforming Breast Cancer Screening

FDA Approves Sotorasib and Panitumumab Combo for KRAS G12C+ Colorectal Cancer

FDA Approves Innovative ADC Datroway for Metastatic HR+, HER2- Breast Cancer

Regulatory Approval Advances Pelareorep’s Virus Therapy for Pancreatic Cancer

FDA Approves 225Ac-SSO110 Radiopharmaceutical Trial for Small Cell Lung Cancer

FDA Grants Priority Review to Datopotamab Deruxtecan for EGFR+ Lung Cancer

The Internet of Medical Things needs a new security model to fulfil its potential

How AI Could Overcome Data Scarcity to Transform Medicine

First-Ever Obstructive Sleep Apnea Drug, Zepbound, Approved by FDA for Obesity

FDA Approves BRAFTOVI Combo as First-Line Treatment for Colorectal Cancer

The Recombinant Polyclonal Drug Candidate GIGA-2339 for Hepatitis B Treatment

How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing